trapoxin a has been researched along with Leukemia, Myeloid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, S; Kawashima, K; Kinoshita, T; Kitamura, K; Kiyoi, H; Kosugi, H; Murate, T; Naoe, T; Saito, H; Tanimoto, M; Towatari, M | 1 |
1 other study(ies) available for trapoxin a and Leukemia, Myeloid
| Article | Year |
|---|---|
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy.
Topics: 3T3 Cells; Acute Disease; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Differentiation; Cell Line; Enzyme Inhibitors; Erythroid Precursor Cells; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Hydroxamic Acids; Leukemia, Myeloid; Megakaryocytes; Mice; Peptides; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 1999 |